Search results
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American biochemist who specializes in ribonucleic acid -mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy.
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
Katalin Karikó. The Nobel Prize in Physiology or Medicine 2023. Born: 17 January 1955, Szolnok, Hungary. Affiliation at the time of the award: Szeged University, Szeged, Hungary; University of Pennsylvania, Philadelphia, PA, USA.
Jul 14, 2024 · Katalin Karikó (born January 17, 1955, Kisújszállás, Hungary) is a Hungarian-born biochemist known for her pioneering research into RNA (ribonucleic acid) therapeutics, particularly the development of messenger RNA (mRNA) vaccines.
Interview with the 2023 Nobel Prize laureate in physiology or medicine Katalin Karikó on 6 December 2023 during the Nobel Week in Stockholm, Sweden. Read the interview.
Oct 2, 2023 · Biochemist Katalin Karikó and immunologist Drew Weissman won the Nobel Prize in Physiology or Medicine Monday for their foundational research showing that chemical modifications to the molecular...
Oct 2, 2023 · The Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19"
Katalin Karikó, PhD, is a biochemist and researcher, best known for her contributions to mRNA technology and the COVID-19 vaccines. Karikó and Drew Weissman, MD, PhD, were jointly awarded the 2023 Nobel Prize in Medicine for their discoveries that enabled the modified mRNA technology used in Pfizer-BioNTech and Moderna’s vaccines to prevent ...
Oct 30, 2023 · The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences.
Oct 1, 2021 · Dr. Katalin Karikó’s research has for decades focused on RNA-mediated mechanisms, with the ultimate goal of developing in vitro-transcribed mRNA for protein therapy.
